The ClearPoint Array Frame: An MRI Compatible System that Supports Non-craniotomy, Multi-trajectory (NCMT) Stereotactic Procedures
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The ClearPoint SmartFrame Array enables complex, multi-trajectory stereotactic procedures for brain cancer treatment. This advanced neuro-oncology technique is safe and effective for accessing distinct tumor regions.
Area Of Science
- Neurosurgery
- Oncology
- Medical Devices
Background
- Stereotactic neurosurgery is evolving with complex multi-trajectory approaches.
- The ClearPoint SmartFrame Array is a second-generation MRI-compatible stereotactic frame designed for advanced procedures.
Purpose Of The Study
- To prospectively evaluate the safety and clinical utility of the ClearPoint SmartFrame Array for non-craniotomy, multi-trajectory (NCMT) stereotactic procedures.
- To establish the feasibility of NCMT procedures in neuro-oncology.
Main Methods
- Ten consecutive patients underwent NCMT stereotactic procedures, including biopsy and laser interstitial thermal therapy, targeting distinct neoplastic regions.
- Procedures were performed under a single anesthetic event using the ClearPoint SmartFrame Array.
Main Results
- The median maximal radial error was 1.0 mm, indicating high accuracy.
- Definitive diagnoses were achieved in all cases, with >90% of targets ablated.
- No procedural complications occurred, with a median hospital stay of 1 day and no 30-day readmissions.
Conclusions
- The ClearPoint Array frame safely and accurately facilitates NCMT stereotactic procedures.
- This technique allows access to geographically distinct regions of brain cancer.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
